Delivery Order SPE2DR25D2104-SPE2DR26F3TDH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,899.94 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. The award was competitively procured under a firm fixed-price contract structure with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Jardiance 25 mg tablets (30-count packages) with a ceiling value of $1,077.32 and an ultimate completion date of January 7, 2026. This is a non-set-aside contract awarded through competitive procurement. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $12,011.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) with a completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $6,762.21 under a firm fixed-price contract structure. The award was made without a set-aside designation, indicating open competition. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $11,313.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $49,813.65 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 17, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a $11,571.48 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. The order was competitively awarded without set-aside restrictions and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $34,205.63 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TDHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,274.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The broader IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Jardiance, a diabetes medication, represents one of numerous pharmaceutical products the company delivers through this contract vehicle to support military treatment facilities and other federal healthcare institutions. The award demonstrates AmerisourceBergen's established capability to fulfill federal procurement requirements for essential prescription medications required by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 1/7/26 |